Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study

M S R Weber,J J Duran Ramirez,M Hentzien,M Cavassini,E Bernasconi,E Hofmann,H Furrer,H Kovari,M Stöckle,P Schmid,D Haerry,D L Braun,H F Günthard,K Kusejko,I Abela,K Aebi-Popp,A Anagnostopoulos,M Battegay,E Bernasconi,DL Braun,HC Bucher,A Calmy,M Cavassini,A Ciuffi,G Dollenmaier,M Egger,L Elzi,J Fehr,J Fellay,H Furrer,CA Fux,HF Günthard,A Hachfeld,D Haerry,B Hasse,HH Hirsch,M Hoffmann,I Hösli,M Huber,D Jackson-Perry,CR Kahlert,O Keiser,T Klimkait,RD Kouyos,H Kovari,K Kusejko,N Labhardt,K Leuzinger,de Martinez,B Tejada,C Marzolini,KJ Metzner,N Müller,J Nemeth,D Nicca,J Notter,P Paioni,G Pantaleo,M Perreau,A Rauch,L Salazar-Vizcaya,P Schmid,R Speck,M Stöckle,P Tarr,A Trkola,G Wandeler,M Weisser,S Yerly,Swiss HIV Cohort Study
DOI: https://doi.org/10.1093/cid/ciae014
IF: 20.999
2024-01-13
Clinical Infectious Diseases
Abstract:Background Advancements in access to antiretroviral therapy (ART) and human immunodeficiency virus (HIV) care have led to a decline in acquired immunodeficiency syndrome (AIDS)-related deaths among people with HIV (PWH) in Switzerland. However, data on the ongoing changes in causes of death among PWH over the past 15 years is scarce. Methods We investigated all reported deaths in the Swiss HIV Cohort Study between 2005-2022. Causes of death were categorized using the Coding Causes of Death in HIV protocol. The statistical analysis included demographic stratification to identify time trends and logistic regression models to determine associated factors for the underlying cause of death. Results In total, 1630 deaths were reported, with 23.7% of individuals assigned female at birth. Out of these deaths, 147 (9.0%) were HIV/AIDS-related, 373 (22.9%) due to non-AIDS, non-hepatic (NANH) cancers, 166 (10.2%) liver-related, and 158 (9.7%) cardiovascular-related. The median age at death increased from 45.0 [40.0,53.0] years in 2005-2007 to 61.0 [56.0,69.5] years in 2020-2022. HIV/AIDS and liver-related causes of death decreased, whereas deaths from NANH cancers increased, and cardiovascular-related deaths remained relatively stable. Conclusion The proportionally decreasing HIV/AIDS and liver-related deaths showcase the effectiveness of ART, comprehensive HIV patient care, and interventions targeting hepatitis C virus co-infection. Future research should focus on managing cancer and cardiovascular-related conditions as the new leading causes of death among PWH. Comprehensive healthcare strategies focusing on non-AIDS-related comorbidities, cancer management, and sustaining liver and cardiovascular health are needed to bridge the ongoing health disparities between PWH and the general population.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?
The paper attempts to address the issue of understanding the changing trends in causes of death among people with HIV (PWH) in Switzerland over the past 15 years. Specifically, the study aims to: 1. **Analyze time trends**: By investigating all reported death cases in the Swiss HIV Cohort Study (SHCS) from 2005 to 2022, analyze the changing trends in causes of death over different time periods. 2. **Identify major causes of death**: Determine the proportional changes in major causes of death such as HIV/AIDS-related deaths, non-AIDS non-hepatocellular carcinoma (NANH) cancers, liver diseases, and cardiovascular diseases. 3. **Explore related factors**: Use logistic regression models to identify factors associated with different causes of death, including demographic characteristics, behavioral factors, clinical indicators, etc. 4. **Provide future research directions**: Based on the study results, propose areas of focus for future research, particularly on how to manage and prevent non-AIDS-related cancers and cardiovascular diseases to reduce health disparities among PWH. Through these analyses, the study hopes to provide a scientific basis for developing comprehensive healthcare strategies to address the new challenges faced by PWH in the era of modern antiretroviral therapy (ART).